$3.09 Billion is the total value of Eventide Asset Management's 122 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 43.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A Ssponsored adr | $191,285,000 | -19.1% | 1,698,648 | 0.0% | 6.19% | -7.0% | |
| SRPT | SAREPTA THERAPEUTICS INC | $97,429,000 | -24.2% | 996,000 | 0.0% | 3.16% | -12.9% | |
| FIVN | Sell | FIVE9 INC | $93,128,000 | +13.6% | 1,218,000 | -2.6% | 3.02% | +30.6% |
| EXAS | Buy | EXACT SCIENCES CORP | $80,736,000 | +76.4% | 1,392,000 | +181.2% | 2.61% | +102.6% |
| ZGNX | ZOGENIX INC | $70,265,000 | -52.6% | 2,841,300 | 0.0% | 2.28% | -45.5% | |
| ROP | ROPER TECHNOLOGIES INC | $66,727,000 | -12.0% | 214,000 | 0.0% | 2.16% | +1.2% | |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $64,878,000 | +300.8% | 901,077 | +319.4% | 2.10% | +360.7% |
| WCN | WASTE CONNECTIONS INC | $62,310,000 | -14.6% | 804,000 | 0.0% | 2.02% | -1.9% | |
| IGV | New | ISHARES TRput | $61,960,000 | – | 291,000 | +100.0% | 2.01% | – |
| TWLO | Sell | TWILIO INCcl a | $61,301,000 | -24.6% | 685,000 | -17.2% | 1.98% | -13.3% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $60,701,000 | -31.8% | 1,783,761 | +9.2% | 1.97% | -21.6% |
| TTD | Sell | THE TRADE DESK INC | $57,900,000 | -47.6% | 300,000 | -29.4% | 1.88% | -39.7% |
| AIMT | Buy | AIMMUNE THERAPEUTICS INC | $55,531,000 | -46.2% | 3,851,000 | +24.9% | 1.80% | -38.2% |
| CRWD | New | CROWDSTRIKE HLDGS INCcl a | $54,956,000 | – | 987,000 | +100.0% | 1.78% | – |
| SPLK | SPLUNK INC | $54,026,000 | -15.7% | 428,000 | 0.0% | 1.75% | -3.1% | |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $53,440,000 | -4.8% | 1,242,800 | +16.6% | 1.73% | +9.5% |
| XYL | Buy | XYLEM INC | $51,648,000 | -17.0% | 793,000 | +0.4% | 1.67% | -4.6% |
| LOW | Buy | LOWES COS INC | $51,337,000 | -27.4% | 596,600 | +1.1% | 1.66% | -16.6% |
| DT | Buy | DYNATRACE INC | $49,501,000 | +137.2% | 2,076,400 | +151.7% | 1.60% | +172.6% |
| MTD | Sell | METTLER TOLEDO INTERNATIONAL | $49,026,000 | -14.9% | 71,000 | -2.2% | 1.59% | -2.2% |
| LRCX | LAM RESEARCH CORP | $48,240,000 | -17.9% | 201,000 | 0.0% | 1.56% | -5.7% | |
| LII | Buy | LENNOX INTL INC | $46,356,000 | -5.0% | 255,000 | +27.5% | 1.50% | +9.2% |
| ASML | Sell | ASML HOLDING N V | $45,002,000 | -15.9% | 172,000 | -4.9% | 1.46% | -3.4% |
| HUBS | Sell | HUBSPOT INC | $44,219,000 | -20.3% | 332,000 | -5.1% | 1.43% | -8.4% |
| VMC | Buy | VULCAN MATLS CO | $43,412,000 | -5.5% | 401,700 | +26.0% | 1.41% | +8.7% |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $39,649,000 | -20.7% | 2,427,976 | 0.0% | 1.28% | -8.8% | |
| SMAR | Sell | SMARTSHEET INC | $39,310,000 | -10.2% | 947,000 | -2.9% | 1.27% | +3.2% |
| ARGX | ARGENX SEsponsored adr | $39,163,000 | -17.9% | 297,300 | 0.0% | 1.27% | -5.7% | |
| BEP | Buy | BROOKFIELD RENEWABLE PARTNERpartnership unit | $38,929,000 | -8.5% | 916,200 | +0.4% | 1.26% | +5.2% |
| CCI | Sell | CROWN CASTLE INTL CORP NEW | $38,396,000 | -16.4% | 265,900 | -17.7% | 1.24% | -3.9% |
| GWPH | GW PHARMACEUTICALS PLCads | $38,181,000 | -16.2% | 436,000 | 0.0% | 1.24% | -3.8% | |
| POOL | Buy | POOL CORPORATION | $36,599,000 | -6.8% | 186,000 | +0.5% | 1.18% | +7.0% |
| IPHI | INPHI CORP | $35,627,000 | +7.0% | 450,000 | 0.0% | 1.15% | +22.9% | |
| IDXX | Buy | IDEXX LABS INC | $34,640,000 | +28.9% | 143,000 | +39.0% | 1.12% | +48.2% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $32,966,000 | +35.2% | 1,212,000 | -1.9% | 1.07% | +55.5% |
| W | WAYFAIR INCcl a | $30,621,000 | -40.9% | 573,000 | 0.0% | 0.99% | -32.0% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $30,552,000 | -19.5% | 353,000 | 0.0% | 0.99% | -7.5% | |
| W | New | WAYFAIR INCcall | $30,000,000 | – | 250,000 | +100.0% | 0.97% | – |
| AVRO | Buy | AVROBIO INC | $29,647,000 | +12.8% | 1,905,307 | +46.0% | 0.96% | +29.7% |
| MYOK | MYOKARDIA INC | $29,112,000 | -35.7% | 621,000 | 0.0% | 0.94% | -26.0% | |
| ODFL | Buy | OLD DOMINION FREIGHT LINE IN | $28,024,000 | +5.2% | 213,500 | +52.1% | 0.91% | +20.8% |
| ROL | New | ROLLINS INC | $27,936,000 | – | 773,000 | +100.0% | 0.90% | – |
| APTV | Buy | APTIV PLC | $27,402,000 | +7.4% | 556,500 | +107.1% | 0.89% | +23.4% |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $27,333,000 | -35.7% | 535,000 | 0.0% | 0.88% | -26.1% | |
| BPMC | BLUEPRINT MEDICINES CORP | $27,018,000 | -27.0% | 462,000 | 0.0% | 0.88% | -16.1% | |
| VRNS | VARONIS SYS INC | $26,741,000 | -18.1% | 420,000 | 0.0% | 0.87% | -5.9% | |
| KALA | New | KALA PHARMACEUTICALS INC | $25,956,000 | – | 2,952,899 | +100.0% | 0.84% | – |
| RNG | New | RINGCENTRAL INCcl a | $25,641,000 | – | 121,000 | +100.0% | 0.83% | – |
| TREX | TREX CO INC | $23,962,000 | -10.8% | 299,000 | 0.0% | 0.78% | +2.5% | |
| QURE | UNIQURE NV | $23,725,000 | -33.8% | 500,000 | 0.0% | 0.77% | -24.0% | |
| PANW | Sell | PALO ALTO NETWORKS INC | $23,256,000 | -65.0% | 141,837 | -50.6% | 0.75% | -59.7% |
| MRTX | MIRATI THERAPEUTICS INC | $23,138,000 | -40.3% | 301,000 | 0.0% | 0.75% | -31.5% | |
| MGA | Buy | MAGNA INTL INC | $22,919,000 | -28.8% | 718,000 | +22.3% | 0.74% | -18.2% |
| SAGE | SAGE THERAPEUTICS INC | $22,689,000 | -60.2% | 790,000 | 0.0% | 0.74% | -54.3% | |
| VCYT | VERACYTE INC | $22,608,000 | -12.9% | 930,000 | 0.0% | 0.73% | 0.0% | |
| DHI | Buy | D R HORTON INC | $22,413,000 | +1913.7% | 659,200 | +3024.2% | 0.73% | +2241.9% |
| NOVT | NOVANTA INC | $22,366,000 | -9.7% | 280,000 | 0.0% | 0.72% | +3.7% | |
| VRSK | New | VERISK ANALYTICS INC | $22,022,000 | – | 158,000 | +100.0% | 0.71% | – |
| STSA | Buy | SATSUMA PHARMACEUTICALS INC | $20,562,000 | +145.8% | 983,382 | +131.4% | 0.67% | +182.2% |
| STML | STEMLINE THERAPEUTICS INC | $20,137,000 | -54.5% | 4,160,608 | 0.0% | 0.65% | -47.7% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $19,739,000 | -38.7% | 1,415,000 | 0.0% | 0.64% | -29.5% | |
| CTAS | CINTAS CORP | $19,227,000 | -35.6% | 111,000 | 0.0% | 0.62% | -26.0% | |
| AY | Buy | ATLANTICA YIELD PLC | $19,216,000 | -8.4% | 861,700 | +8.4% | 0.62% | +5.2% |
| HASI | Buy | HANNON ARMSTRONG SUST INFR C | $17,238,000 | -29.7% | 844,600 | +10.9% | 0.56% | -19.1% |
| REGN | New | REGENERON PHARMACEUTICALS | $15,088,000 | – | 30,900 | +100.0% | 0.49% | – |
| XENE | XENON PHARMACEUTICALS INC | $14,448,000 | -13.5% | 1,274,100 | 0.0% | 0.47% | -0.6% | |
| CRNX | CRINETICS PHARMACEUTICALS IN | $13,921,000 | -41.4% | 947,000 | 0.0% | 0.45% | -32.6% | |
| LW | Buy | LAMB WESTON HLDGS INC | $13,841,000 | +410.7% | 242,400 | +669.5% | 0.45% | +489.5% |
| OKTA | Buy | OKTA INCcl a | $13,204,000 | +14.4% | 108,000 | +8.0% | 0.43% | +31.7% |
| STRO | Buy | SUTRO BIOPHARMA INC | $13,117,000 | -4.2% | 1,285,975 | +3.3% | 0.42% | +10.1% |
| XLRN | New | ACCELERON PHARMA INC | $12,842,000 | – | 142,900 | +100.0% | 0.42% | – |
| KALV | KALVISTA PHARMACEUTICALS INC | $12,852,000 | -57.0% | 1,680,000 | 0.0% | 0.42% | -50.7% | |
| ISRG | INTUITIVE SURGICAL INC | $12,380,000 | -16.2% | 25,000 | 0.0% | 0.40% | -3.6% | |
| SWKS | New | SKYWORKS SOLUTIONS INC | $12,084,000 | – | 135,200 | +100.0% | 0.39% | – |
| SGEN | New | SEATTLE GENETICS INC | $11,826,000 | – | 102,500 | +100.0% | 0.38% | – |
| DDOG | Buy | DATADOG INC | $11,837,000 | +4.4% | 329,000 | +9.7% | 0.38% | +20.1% |
| MDB | Sell | MONGODB INCcl a | $11,742,000 | -3.5% | 86,000 | -7.0% | 0.38% | +10.8% |
| PHAT | PHATHOM PHARMACEUTICALS INC | $11,619,000 | -17.1% | 450,000 | 0.0% | 0.38% | -4.8% | |
| RGEN | REPLIGEN CORP | $11,488,000 | +4.4% | 119,000 | 0.0% | 0.37% | +20.0% | |
| MGTA | Sell | MAGENTA THERAPEUTICS INC | $11,239,000 | -78.2% | 1,789,646 | -47.3% | 0.36% | -74.9% |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $10,827,000 | – | 45,500 | +100.0% | 0.35% | – |
| XPO | XPO LOGISTICS INC | $10,725,000 | -38.8% | 220,000 | 0.0% | 0.35% | -29.8% | |
| EIDX | New | EIDOS THERAPEUTICS INC | $10,435,000 | – | 213,000 | +100.0% | 0.34% | – |
| GLPG | GALAPAGOS NVspon adr | $9,992,000 | -5.3% | 51,000 | 0.0% | 0.32% | +9.1% | |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $10,004,000 | – | 243,000 | +100.0% | 0.32% | – |
| ARVN | New | ARVINAS INC | $9,269,000 | – | 230,000 | +100.0% | 0.30% | – |
| ARYAU | ARYA SCIENCES ACQUISITION COunit 10/04/2023 | $9,032,000 | -1.8% | 800,000 | 0.0% | 0.29% | +12.7% | |
| XNCR | XENCOR INC | $8,964,000 | -13.1% | 300,000 | 0.0% | 0.29% | -0.3% | |
| ETNB | 89BIO INC | $8,838,000 | -4.0% | 350,000 | 0.0% | 0.29% | +10.4% | |
| MKC | New | MCCORMICK & CO INC | $8,473,000 | – | 60,000 | +100.0% | 0.27% | – |
| EPIX | ESSA PHARMA INC | $7,639,000 | -27.3% | 2,010,169 | 0.0% | 0.25% | -16.6% | |
| ALLK | New | ALLAKOS INC | $7,118,000 | – | 160,000 | +100.0% | 0.23% | – |
| MYOV | Sell | MYOVANT SCIENCES LTD | $6,040,000 | -90.6% | 800,000 | -80.6% | 0.20% | -89.1% |
| EQIX | Buy | EQUINIX INC | $4,372,000 | +62.8% | 7,000 | +52.2% | 0.14% | +86.8% |
| FENC | FENNEC PHARMACEUTICALS INC | $4,277,000 | -8.3% | 720,000 | 0.0% | 0.14% | +6.1% | |
| NEE | Buy | NEXTERA ENERGY INC | $4,187,000 | +31.0% | 17,400 | +31.8% | 0.14% | +51.1% |
| CMS | Buy | CMS ENERGY CORP | $4,095,000 | +38.7% | 69,700 | +48.3% | 0.13% | +60.2% |
| AQN | New | ALGONQUIN PWR UTILS CORP | $3,823,000 | – | 285,300 | +100.0% | 0.12% | – |
| WEC | New | WEC ENERGY GROUP INC | $3,516,000 | – | 39,900 | +100.0% | 0.11% | – |
| JKHY | New | HENRY JACK & ASSOC INC | $3,446,000 | – | 22,200 | +100.0% | 0.11% | – |
| A | Buy | AGILENT TECHNOLOGIES INC | $3,373,000 | +20.9% | 47,100 | +44.0% | 0.11% | +38.0% |
| ARE | Sell | ALEXANDRIA REAL ESTATE EQ IN | $3,303,000 | -16.2% | 24,100 | -1.2% | 0.11% | -3.6% |
| PLD | Buy | PROLOGIS INC. | $3,159,000 | -4.0% | 39,300 | +6.5% | 0.10% | +9.7% |
| WM | Buy | WASTE MGMT INC DEL | $2,805,000 | +15.6% | 30,300 | +42.3% | 0.09% | +33.8% |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $2,487,000 | – | 226,680 | +100.0% | 0.08% | – |
| KLAC | Buy | KLA CORPORATION | $2,257,000 | +122.1% | 15,700 | +175.4% | 0.07% | +151.7% |
| ELS | New | EQUITY LIFESTYLE PPTYS INC | $2,173,000 | – | 37,800 | +100.0% | 0.07% | – |
| ETTX | ENTASIS THERAPEUTICS HLDGS I | $2,131,000 | -50.4% | 879,541 | 0.0% | 0.07% | -43.0% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $2,033,000 | -45.2% | 270,000 | 0.0% | 0.07% | -37.1% | |
| SHW | New | SHERWIN WILLIAMS CO | $1,976,000 | – | 4,300 | +100.0% | 0.06% | – |
| ZTS | Buy | ZOETIS INCcl a | $1,671,000 | +26.2% | 14,200 | +42.0% | 0.05% | +45.9% |
| TER | Buy | TERADYNE INC | $1,647,000 | +121.7% | 30,400 | +178.9% | 0.05% | +152.4% |
| TT | New | TRANE TECHNOLOGIES PLC | $1,635,000 | – | 19,800 | +100.0% | 0.05% | – |
| IMVTW | New | IMMUNOVANT INC*w exp 12/18/202 | $1,565,000 | – | 651,900 | +100.0% | 0.05% | – |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $1,536,000 | -8.4% | 15,200 | +35.7% | 0.05% | +6.4% |
| Sell | NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,398,000 | -30.0% | 1,087,000 | -16.4% | 0.04% | -19.6% | |
| IEX | Buy | IDEX CORP | $1,284,000 | -18.8% | 9,300 | +1.1% | 0.04% | -6.7% |
| FRC | Sell | FIRST REP BK SAN FRANCISCO C | $1,012,000 | -60.3% | 12,300 | -43.3% | 0.03% | -54.2% |
| New | EXACT SCIENCES CORPnote 1.000% 1/1 | $795,000 | – | 730,000 | +100.0% | 0.03% | – | |
| Sell | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $584,000 | -37.9% | 384,000 | -20.5% | 0.02% | -29.6% | |
| CCIPRA | New | CROWN CASTLE INTL CORP NEW6.875% con pfd a | $400,000 | – | 320 | +100.0% | 0.01% | – |
| CCOI | New | COGENT COMMUNICATIONS HLDGS | $254,000 | – | 3,100 | +100.0% | 0.01% | – |
| MLHR | Exit | MILLER HERMAN INC | $0 | – | -9,200 | -100.0% | -0.01% | – |
| CCIPRA | Exit | CROWN CASTLE INTL CORP NEW6.875% con pfd a | $0 | – | -320 | -100.0% | -0.01% | – |
| SIVB | Exit | SVB FINL GROUP | $0 | – | -2,300 | -100.0% | -0.02% | – |
| INFO | Exit | IHS MARKIT LTD | $0 | – | -9,400 | -100.0% | -0.02% | – |
| Exit | INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $0 | – | -820,000 | -100.0% | -0.02% | – | |
| FNB | Exit | FNB CORP PA | $0 | – | -76,800 | -100.0% | -0.03% | – |
| BWA | Exit | BORGWARNER INC | $0 | – | -22,200 | -100.0% | -0.03% | – |
| Exit | INTERCEPT PHARMACEUTICALS INnote 2.000% 5/1 | $0 | – | -736,000 | -100.0% | -0.03% | – | |
| JCI | Exit | JOHNSON CTLS INTL PLC | $0 | – | -47,800 | -100.0% | -0.06% | – |
| Exit | PALO ALTO NETWORKS INCnote 0.750% 7/0 | $0 | – | -1,890,000 | -100.0% | -0.06% | – | |
| IR | Exit | INGERSOLL-RAND PLC | $0 | – | -17,400 | -100.0% | -0.06% | – |
| BXP | Exit | BOSTON PROPERTIES INC | $0 | – | -17,500 | -100.0% | -0.07% | – |
| OKE | Exit | ONEOK INC NEW | $0 | – | -40,800 | -100.0% | -0.09% | – |
| FHN | Exit | FIRST HORIZON NATL CORP | $0 | – | -197,300 | -100.0% | -0.09% | – |
| EXR | Exit | EXTRA SPACE STORAGE INC | $0 | – | -110,000 | -100.0% | -0.33% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -100,000 | -100.0% | -0.35% | – |
| IMVTU | Exit | IMMUNOVANT INCunit 12/18/2024 added | $0 | – | -680,000 | -100.0% | -0.48% | – |
| PFPT | Exit | PROOFPOINT INC | $0 | – | -158,000 | -100.0% | -0.51% | – |
| ESTC | Exit | ELASTIC N V | $0 | – | -320,000 | -100.0% | -0.58% | – |
| LEA | Exit | LEAR CORP | $0 | – | -184,000 | -100.0% | -0.71% | – |
| PAYC | Exit | PAYCOM SOFTWARE INC | $0 | – | -100,000 | -100.0% | -0.75% | – |
| IAA | Exit | IAA INC | $0 | – | -610,000 | -100.0% | -0.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 40 | Q3 2023 | 3.2% |
| PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
| ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
| VERACYTE INC | 38 | Q3 2023 | 1.5% |
| LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
| MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
| ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
| KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
| Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
| SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.